Microcurrent therapy has quietly moved from hospital rehabilitation rooms into the hands of athletes, pain patients, and everyday users — yet most people still ask the same first question: what exactly is it? Understanding microcurrent therapy (also called MET, or Microcurrent Electro Therapy) starts with understanding something your own body already does every second of every day.
Every cell in the human body generates and transmits tiny electrical signals. Nerve impulses, muscle contractions, and even the healing of a cut all depend on precise bioelectrical activity at the cellular level. When tissue is injured, damaged, or under chronic stress, these electrical signals become disrupted — and recovery slows down.
Microcurrent therapy works by delivering very low-level electrical currents — measured in microamperes (μA), one millionth of an ampere — that mimic the body's own bioelectrical signals. These currents are so gentle that most users feel little or nothing during a session. Yet at the cellular level, something significant happens.
The most studied mechanism behind microcurrent therapy is its effect on ATP (adenosine triphosphate) — the primary energy currency of every living cell. Research has shown that microcurrent stimulation at the right frequency and intensity can increase ATP production in cells by a significant margin compared to untreated tissue.
Why does ATP matter? Because your cells cannot repair themselves, divide, or carry out normal functions without it. When ATP production is abundant, cellular repair accelerates. When it is depleted — as happens in chronic injury, prolonged fatigue, or inflammation — recovery stalls. By supporting ATP synthesis, microcurrent therapy creates the cellular conditions in which the body can do its own healing work more effectively.
Additionally, microcurrent stimulation has been observed to support protein synthesis and enhance the transport of amino acids into cells — both of which are essential for tissue repair and regeneration.
Three technologies are frequently confused: TENS (Transcutaneous Electrical Nerve Stimulation), EMS (Electrical Muscle Stimulation), and MET (Microcurrent Electro Therapy). They share the use of electrical current delivered through electrode pads on the skin, but they work in fundamentally different ways.
• TENS operates in the milliampere range (mA) and works primarily by blocking pain signals from reaching the brain — essentially an electrical 'gate' on the nervous system. It provides symptomatic pain relief while in use but generally has no effect once switched off.
• EMS operates at even higher currents and is designed to cause visible muscle contractions. It is used in sports training for muscle activation and in clinical settings for patients who cannot voluntarily contract muscles (e.g. after stroke or surgery).
• MET (Microcurrent) operates at currents 1,000 times lower than TENS — in the microampere range. At these levels, no muscle contraction occurs and no nerve blocking takes place. Instead, the current works at the cellular level to support ATP production, reduce inflammation, and assist natural repair processes. The effects may persist beyond the treatment session.
The key distinction is the mechanism: TENS and EMS override or stimulate the body's signals from the outside. Microcurrent therapy works within the body's own bioelectrical range, essentially speaking the same language as the cells themselves.
Microcurrent research dates back to the 1980s, when orthopedic surgeon Dr. Robert O. Becker pioneered work on bioelectricity and tissue regeneration. His foundational studies showed that electrical currents matching the body's own signals could dramatically influence healing outcomes — work that laid the groundwork for the modern medical applications of microcurrent.
More recently, a clinical study conducted at Hasselt University investigated the effects of microcurrent electrotherapy on pain and recovery. The study provided empirical support for the use of MET devices in pain management contexts, adding to a growing body of peer-reviewed literature on electrostimulation and tissue response.
It is important to note that research continues to evolve, and individual responses to microcurrent therapy vary. As with any therapeutic modality, microcurrent works best as part of a broader approach to health and recovery — not as a standalone cure.
In its FDA-cleared form, microcurrent therapy devices like the KFH Energy are classified as pain relief devices — specifically cleared under 21 CFR 882.5890 as transcutaneous electrical nerve stimulators for pain relief (510(k) K073008). This means the primary, evidence-supported, and regulatory-approved use is pain management.
Within the European Union, CE-marked Class IIa devices may carry additional indications depending on the clinical evidence submitted for certification. Always consult the device's instructions for use and, if in doubt, speak with your healthcare provider about whether microcurrent therapy is appropriate for your specific situation.
The KFH Energy by KFHealth is a compact, portable microcurrent electrotherapy device designed for home and professional use. Unlike bulky clinical systems, the KFH Energy fits in your hand and delivers the same quality of microcurrent stimulation via adhesive electrode pads that can be placed on any area of the body experiencing pain or discomfort.
The device is FDA-cleared (510(k) K073008), CE-marked as a Class IIa medical device, and manufactured under ISO 13485 quality management standards — giving users the confidence that it has met the standards expected of a legitimate medical device, not a consumer gadget.
Microcurrent therapy is suitable for a wide range of adults experiencing pain or physical discomfort. It is commonly used by people managing chronic pain conditions, athletes looking to support recovery from training-related muscle soreness, and individuals seeking a drug-free complement to their existing pain management plan.
It is not intended to replace medical diagnosis or treatment. If you are experiencing persistent, severe, or unexplained pain, always consult a qualified healthcare professional before beginning any new therapeutic approach — including microcurrent therapy.
DISCLAIMER: KFH Energy is an FDA-cleared medical device for pain relief (510(k) K073008). Always consult a healthcare professional before use, particularly if you have an implanted pacemaker, are pregnant, or have a serious medical condition. Individual results may vary.
